ATTO
NASD Attovia Therapeutics, Inc.$13.73 ↑ +0.00 (+0.00%) Trading Up from the previous close of $13.73, $1.81 below the day’s high of $15.54
- YTD change
- -37.31%
- vs 20-day SMA
- -21.57%
- vs 200-day SMA
- N/A
Price ranges
Price & Performance
-7.12 (-32.51%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 51.0% away from all-time highs of $28.00
- ATTO is down 37% since the beginning of the year
- ATTO is down 37% over the past 12 months
- ATTO is down 40% over the past 1 month
- 3% of all ATTO investors are betting against ATTO
ATTO reads poor: the 12-month move is -32.5%.
- Previous minute
- +$0.00
- Last hour
- +$0.16
- Last 5 days
- -15.82%
- vs 8-day SMA
- -12.47%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Attovia Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that creates next-generation biologic medicines for immune-mediated diseases. It was founded in 2022 and is headquartered in San Carlos, CA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.